ZA915366B - Diphenylmethyl piperazine derivatives - Google Patents

Diphenylmethyl piperazine derivatives

Info

Publication number
ZA915366B
ZA915366B ZA915366A ZA915366A ZA915366B ZA 915366 B ZA915366 B ZA 915366B ZA 915366 A ZA915366 A ZA 915366A ZA 915366 A ZA915366 A ZA 915366A ZA 915366 B ZA915366 B ZA 915366B
Authority
ZA
South Africa
Prior art keywords
piperazine derivatives
action
diphenylmethyl piperazine
cardiac muscles
diphenylmethyl
Prior art date
Application number
ZA915366A
Other languages
English (en)
Inventor
Noboru Kaneko
Kaneko Noboru
Makoto Takeishi
Takeishi Makoto
Tatsushi Oosawa
Oosawa Tatsushi
Kouji Akimoto
Akimoto Kouji
Hideo Oota
Oota Hideo
Tatsuo Nakajima
Nakajima Tatsuo
Original Assignee
Kaneko Noboru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneko Noboru filed Critical Kaneko Noboru
Publication of ZA915366B publication Critical patent/ZA915366B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ZA915366A 1990-07-10 1991-07-10 Diphenylmethyl piperazine derivatives ZA915366B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2182095A JP2651043B2 (ja) 1990-07-10 1990-07-10 ジフェニルメチルピペラジン誘導体

Publications (1)

Publication Number Publication Date
ZA915366B true ZA915366B (en) 1992-04-29

Family

ID=16112265

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915366A ZA915366B (en) 1990-07-10 1991-07-10 Diphenylmethyl piperazine derivatives

Country Status (12)

Country Link
US (1) US5304558A (ru)
EP (1) EP0541802B1 (ru)
JP (1) JP2651043B2 (ru)
CN (1) CN1037840C (ru)
AT (1) ATE112764T1 (ru)
AU (1) AU8212591A (ru)
CA (1) CA2087032C (ru)
DE (1) DE69104615T2 (ru)
RU (1) RU2091379C1 (ru)
TW (1) TW198717B (ru)
WO (1) WO1992000962A1 (ru)
ZA (1) ZA915366B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658963A (en) * 1995-02-02 1997-08-19 Bisco, Inc. One-component primer/bonding-resin systems
ATE349212T1 (de) 1999-09-30 2007-01-15 Noboru Kaneko Mittel gegen krebs
IL151923A0 (en) * 2000-03-31 2003-04-10 Pfizer Prod Inc Novel piperazine derivatives
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
EP1423381B1 (en) * 2001-09-06 2007-01-03 Schering Corporation 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ１ライアノジン受容体に基づく方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
JP5318938B2 (ja) 2011-06-09 2013-10-16 株式会社アエタスファルマ ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物
JP6021616B2 (ja) * 2012-12-04 2016-11-09 株式会社アエタスファルマ ３−ピペラジニル−１−ピペリジニル−プロパン誘導体及びそれを含有してなる医薬組成物
KR102257892B1 (ko) 2014-11-26 2021-05-28 삼성전자주식회사 개선된 ｎｆｃ 안테나 및 그 안테나를 갖는 전자 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR65270B (en) * 1978-10-10 1980-07-31 Fujisawa Pharmaceutical Co Isatin derivatives and processes for the preparation thereof
DE3536797A1 (de) * 1985-10-16 1987-04-16 Studiengesellschaft Kohle Mbh Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung
HU198052B (en) * 1986-02-14 1989-07-28 Sandoz Ag Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds
ZA871078B (en) * 1986-02-14 1988-09-28 Sandoz Ltd Purine derivatives,their preparation and medicaments containing them
US4885300A (en) * 1988-03-03 1989-12-05 Ortho Pharmaceutical Corporation 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives
US5215987A (en) * 1990-04-23 1993-06-01 Ortho Pharmaceutical Corporation Substituted benzhydryl 2-hydroxypropyl piperazine derivatives

Also Published As

Publication number Publication date
EP0541802B1 (en) 1994-10-12
AU8212591A (en) 1992-02-04
DE69104615D1 (de) 1994-11-17
DE69104615T2 (de) 1995-03-23
RU2091379C1 (ru) 1997-09-27
JP2651043B2 (ja) 1997-09-10
JPH0469377A (ja) 1992-03-04
ATE112764T1 (de) 1994-10-15
CN1037840C (zh) 1998-03-25
EP0541802A4 (en) 1993-05-26
EP0541802A1 (en) 1993-05-19
CN1058963A (zh) 1992-02-26
TW198717B (ru) 1993-01-21
CA2087032C (en) 1999-06-15
US5304558A (en) 1994-04-19
CA2087032A1 (en) 1992-01-11
WO1992000962A1 (fr) 1992-01-23

Similar Documents

Publication Publication Date Title
ZA915366B (en) Diphenylmethyl piperazine derivatives
DK0698606T3 (da) Azolylaminderivat
DK91889A (da) 5-lipoxygenaseinhiberende 4-(4-phenyl-1-piperazinyl)phenoler
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
NO922147L (no) Heterocykliske derivater
IL92482A0 (en) Substituted thiazoles and their use as fungicides
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DK0378255T3 (da) 2-aminopyrimidinoderivater
DK0511541T3 (ru)
ATE260104T1 (de) Hemmung der endprodukte fortgeschrittener glykolisierung
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
DK0609289T3 (da) Imidazolderivater og farmaceutiske præparater med indhold deraf
ES2093091T3 (es) Derivado de glutation.
GR3034746T3 (en) Akyl Substituted heterocyclic compounds.
ATE114309T1 (de) N-azabicyclo(3.3.0>octanamide von aromatischen säuren.
AU561008B2 (en) N,n,-disubstituted alkenamides and phenylalkenamides and heterocyclic starting compounds
ES2115178T3 (es) Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.
IL102648A0 (en) Pharmaceutical compositions for treating diabetes,comprising 1,4-dihydropyridines
CA1270833C (en) 2,5-PYRROLIDINEDIONE DERIVATIVES USEFUL AS ANTI-ARHYTMIZING AGENTS
EP0653207A4 (en) AIDS VIRUS INFECTIVE COMPOSITION.
ATE154243T1 (de) Hemmstoff der blutgefässhypertrophie